DYRK1B and ovarian cancer: We next investigated the effects of constitutively expressed Mirk on sensitivity of ovarian cancer cells to conventional chemotherapeutics, Mirk siRNA-treated OV2008, OVCAR5, and OVCAR8 cells were exposed to indicated dose of cisplatin for apoptosis assays.